Commentary on Chang et al. (2018): Assessing prescribing volume and patient risk-implementation considerations

Suzanne Nielsen^{1

2}, Kari Lancaster³

Affiliations

¹ National Drug and Alcohol Research Centre, UNSW, Randwick, NSW, Australia.
² South Eastern Sydney Local Health District Drug and Alcohol Services, Sydney, NSW, Australia.
³ Centre for Social Research in Health, UNSW, Sydney, NSW, Australia.

Comment

Suzanne Nielsen et al. Addiction. 2018 Apr.

. 2018 Apr;113(4):687-688.

doi: 10.1111/add.14138.

Suzanne Nielsen^{1

2}, Kari Lancaster³

¹ National Drug and Alcohol Research Centre, UNSW, Randwick, NSW, Australia.
² South Eastern Sydney Local Health District Drug and Alcohol Services, Sydney, NSW, Australia.
³ Centre for Social Research in Health, UNSW, Sydney, NSW, Australia.

No abstract available

Keywords: Guidelines; implementation; prescribing; prescription monitoring; prescription opioids; risk profile.

Comment on

Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers.
Chang HY, Murimi IB, Jones CM, Alexander GC. Chang HY, et al. Addiction. 2018 Apr;113(4):677-686. doi: 10.1111/add.14068. Epub 2017 Nov 29. Addiction. 2018. PMID: 29193546